Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT

Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT

Abstract Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is triggered by nCOV-19 adenovirus-vectored vaccines against SARS-CoV2. Pathogenesis has been mainly related to platelet activation via PF4-reactive antibodies that activate platelets and may cross-react with heparin....

Full description

Bibliographic Details
Main Authors: Lasse Myllylahti, Hanna Pitkänen, Harry Magnani, Riitta Lassila
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Thrombosis Journal
Subjects:
COVID19
Vaccination
PF4 antibody
VITT
Autoimmune HIT
Danaparoid sodium
Online Access:https://doi.org/10.1186/s12959-021-00362-y

Internet

https://doi.org/10.1186/s12959-021-00362-y

Similar Items